Agios Pharmaceuticals Inc... (AGIO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

38.97

-0.31%

After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	26.82M	14.24M	-	203.20M	117.91M	94.39M	43.01M	69.89M	59.12M	65.36M	25.55M	25.11M	21.84M
Cost of Revenue	9.50M	1.70M	18.78M	2.81M	1.32M	1.40M	292.68M	220.16M	141.83M	100.37M	54.50M	41.04M	-
Gross Profit	17.32M	12.54M	-18.78M	200.39M	116.59M	92.99M	-249.67M	-150.27M	-82.71M	-35.01M	-28.95M	-15.93M	21.84M
Operating Income	-391.49M	-389.05M	-378.42M	-316.15M	-426.33M	-362.48M	-320.79M	-200.99M	-118.70M	-54.13M	-38.88M	-23.00M	-16.63M
Interest Income	33.34M	12.79M	836.00K	6.61M	14.86M	16.45M	6.12M	2.51M	968.00K	203.00K	55.00K	69.00K	132.00K
Pretax Income	-352.09M	-231.80M	-356.51M	-327.37M	-411.47M	-346.03M	-314.67M	-198.47M	-117.73M	-53.93M	-38.83M	-22.93M	-16.50M
Net Income	-352.09M	-74.56M	1.60B	-335.22M	-396.61M	-346.03M	-314.67M	-198.47M	-117.73M	-53.50M	-39.41M	-20.10M	-23.71M
Selling & General & Admin	119.90M	121.67M	121.44M	149.07M	132.03M	114.14M	71.12M	50.71M	35.99M	19.12M	9.93M	7.06M	7.21M
Research & Development	288.90M	279.91M	256.97M	367.47M	410.89M	341.32M	292.68M	220.16M	141.83M	100.37M	54.50M	41.04M	31.25M
Other Expenses	-	6.75M	14.43M	-	-	-	-	-	-	-	-	-	-
Operating Expenses	408.81M	401.58M	378.42M	516.54M	542.93M	455.47M	363.81M	270.88M	177.82M	119.49M	64.43M	48.10M	38.47M
Interest Expense	-	12.79M	-	17.83M	-	16.45M	6.12M	2.51M	968.00K	203.00K	55.00K	69.00K	132.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	418.31M	403.29M	378.42M	519.35M	544.25M	456.87M	363.81M	270.88M	177.82M	119.49M	64.43M	48.10M	38.47M
Income Tax	-	-157.25M	-1.98B	7.85M	-14.86M	32.90M	-6.43M	-5.71M	-426.00K	-426.00K	579.00K	-2.82M	7.21M
Shares Outstanding (Basic)	55.65M	54.79M	60.45M	69.00M	59.99M	57.42M	46.59M	39.13M	37.43M	33.67M	15.41M	23.39M	23.39M
Shares Outstanding (Diluted)	55.65M	54.79M	60.45M	69.00M	59.99M	57.42M	46.59M	39.13M	37.43M	33.67M	15.41M	23.39M	23.39M
EPS (Basic)	-6.33	-1.36	26.55	-4.86	-6.61	-6.03	-6.75	-5.07	-3.15	-1.59	-2.56	-0.86	-1.01
EPS (Diluted)	-6.33	-1.36	26.55	-4.86	-6.61	-6.03	-6.75	-5.07	-3.15	-1.59	-2.56	-0.86	-1.01
EBITDA	-384.86M	-380.48M	-337.73M	-326.13M	-394.85M	-338.86M	-314.36M	-195.28M	-115.36M	-52.77M	-37.44M	-21.82M	-15.83M
Depreciation & Amortization	6.62M	18.56M	18.78M	18.77M	16.62M	7.17M	6.43M	5.71M	3.34M	1.37M	1.44M	1.18M	801.00K